Table 2.

Multivariable logistic regression analysis showing the association between administration of tofacitinib timings with survival status.

	Adjusted odds ratio	95% confidence interval	P value
Model 1	19.3	2.57, 145.2	.001
Model 2	22.7	1.18, 435.8	.038
Model 3	33.7	3.81, 298.7	.002

Model 1: Association of administration of tofacitinib and survival status adjusted for age, presence of diabetes, duration of illness before hospitalization.

Model 2: Association of administration of tofacitinib and survival status adjusted for age, presence of diabetes, duration of illness before hospitalization and disease severity score.

Model 3: Association of administration of tofacitinib and survival status adjusted for age, glycated hemoglobin levels, duration of illness before hospitalization and disease severity scores.